Gomisin G
Gomisin G is a lignin from S. chinesis with anti-HIV (EC50 = 0.006 μg/mL), anti-liver cancer and anti-inflammatory activities. Gomisin G has an AKT-cyclin D1 dependent mechanism against triple-negative breast cancer (TNBC) cells through suppressing phosphorylation rather than inducing apoptosis. Gomisin G can inhibit AKT phosphorylation. Gomisin G can cause cell cycle arrest in the G1 phase. Gomisin G can be studied in research for diseases such as HIV, breast and liver cancers[1][2][3].
Product Specifications
CAS Number
62956-48-3
UNSPSC
12352005
Target
HIV
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Gomisin-G.html
Purity
99.93
Solubility
DMSO : ≥ 50 mg/mL
Smiles
COC1=C(OCO2)C2=CC([C@H](OC(C3=CC=CC=C3)=O)[C@](O)(C)[C@@H](C)C4)=C1C(C4=CC(OC)=C5OC)=C5OC
Molecular Formula
C30H32O9
Molecular Weight
536.57
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Canine campylobacter jejuni,CJ antibody,IgG ELISA KIT
Human Synaptopodin 2-like protein, SYNPO2L ELISA KIT
Itpr1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Monoclonal Antibody to Interleukin 12B (IL12B)